| 000 | 01738 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513073954.0 | ||
| 264 | 0 | _c19931004 | |
| 008 | 199310s 0 0 eng d | ||
| 022 | _a0918-6158 | ||
| 024 | 7 |
_a10.1248/bpb.16.571 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOhmori, S | |
| 245 | 0 | 0 |
_aStudies on cytochrome P450 responsible for oxidative metabolism of imipramine in human liver microsomes. _h[electronic resource] |
| 260 |
_bBiological & pharmaceutical bulletin _cJun 1993 |
||
| 300 |
_a571-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCytochrome P-450 Enzyme Inhibitors |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _ximmunology |
| 650 | 0 | 4 |
_aDesipramine _xmetabolism |
| 650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImipramine _xmetabolism |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xdrug effects |
| 650 | 0 | 4 |
_aMixed Function Oxygenases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNADPH-Ferrihemoprotein Reductase _xmetabolism |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aOxidoreductases, N-Demethylating _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPropranolol _xpharmacology |
| 650 | 0 | 4 |
_aQuinidine _xpharmacology |
| 650 | 0 | 4 |
_aQuinine _xpharmacology |
| 650 | 0 | 4 |
_aTestosterone _xmetabolism |
| 650 | 0 | 4 |
_aTroleandomycin _xpharmacology |
| 700 | 1 | _aTakeda, S | |
| 700 | 1 | _aRikihisa, T | |
| 700 | 1 | _aKiuchi, M | |
| 700 | 1 | _aKanakubo, Y | |
| 700 | 1 | _aKitada, M | |
| 773 | 0 |
_tBiological & pharmaceutical bulletin _gvol. 16 _gno. 6 _gp. 571-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1248/bpb.16.571 _zAvailable from publisher's website |
| 999 |
_c8363784 _d8363784 |
||